DORATIQ

Serial Number 87684061
606

Registration Progress

Application Filed
Nov 14, 2017
Under Examination
May 29, 2018
Approved for Publication
Apr 3, 2018
Published for Opposition
Apr 3, 2018
Registered

Trademark Image

DORATIQ

Basic Information

Serial Number
87684061
Filing Date
November 14, 2017
Published for Opposition
April 3, 2018
Abandonment Date
January 4, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 4, 2021
Classes
005 010

Rights Holder

EYEPOINT PHARMACEUTICALS US, INC.

03
Address
480 PLEASANT STREET, SUITE B300
WATERTOWN, MA 02472

Ownership History

pSivida US, Inc.

Original Applicant
03
Watertown, MA

pSivida US, Inc.

Owner at Publication
03
Watertown, MA

EYEPOINT PHARMACEUTICALS US, INC.

New Owner After Publication #1
03
WATERTOWN, MA

Legal Representation

Attorney
Kimberly Jarman, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Jan 4, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 4, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 29, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 29, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 29, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 29, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 29, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 29, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 28, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 26, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 26, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 26, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 23, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 21, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 21, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 21, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 24, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 24, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 24, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 27, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 25, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 25, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 25, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 29, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 18, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 3, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 3, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 14, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 27, 2018 DMCC I DATA MODIFICATION COMPLETED Loading...
Feb 27, 2018 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 27, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 7, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 7, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 27, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 17, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections
Class 010
Sustained drug delivery systems for pharmaceuticals

Classification

International Classes
005 010